Clusterin inhibition mediates sensitivity to chemotherapy and radiotherapy in human cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Anti-Cancer Drugs

• Publication date

  2017-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/CAD.0000000000000507PMID 28471806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clusterin immunoexpression is associated with early stage endometrial carcinomas.

  2016cited by this paper
• Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib.

  2016cited by this paper
• miRNA-378 reverses chemoresistance to cisplatin in lung adenocarcinoma cells by targeting secreted clusterin

  2016cited by this paper
• The CLU-files: disentanglement of a mystery

  2016cited by this paper
• The Role of Clusterin in Carcinogenesis and its Potential Utility as Therapeutic Target.

  2016cited by this paper
• Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells

  2015cited by this paper
• Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma HepG2/ADM cells

  2015cited by this paper
• sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo

  2015cited by this paper
• [Protein levels and its clinical significance of septin-9 and clusterin in peripheral blood of epithelial ovarian cancer patients].

  2015cited by this paper
• Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma

  2015cited by this paper
• Clinical experiences with systemically administered siRNA-based therapeutics in cancer

  2015cited by this paper
• Ensembl Genomes 2016: more genomes, more complexity

  2015cited by this paper
• Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)

  2015cited by this paper
• Clusterin glycopeptide variant characterization reveals significant site-specific glycan changes in the plasma of clear cell renal cell carcinoma.

  2015cited by this paper
• Insights into Chemoresistance of Prostate Cancer

  2015cited by this paper
• The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer.

  2015cited by this paper
• Downregulation of clusterin mediates sensitivity to protein kinase inhibitors in breast cancer cells

  2015cited by this paper
• Phase III SYNERGY trial: Docetaxel +/- custirsen and overall survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and poor prognosis.

  2015cited by this paper
• siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer

  2015cited by this paper
• Effects of down-regulation of clusterin by small interference RNA on human acute myeloid leukemia cells.

  2015cited by this paper
• Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death.

  2015cited by this paper
• Multimodel ensembles of wheat growth: many models are better than one

  2015cited by this paper
• Clusterin silencing sensitizes pancreatic cancer MIA-PaCa-2 cells to gmcitabine via regulation of NF-kB/Bcl-2 signaling.

  2015cited by this paper
• Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells.

  2015cited by this paper
• Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study

  2015cited by this paper
• Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy?

  2015cited by this paper
• Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic

  2014cited by this paper
• Secreted Clusterin Gene Silencing Enhances Chemosensitivity of A549 Cells to Cisplatin Through AKT and ERK1/2 Pathways in Vitro

  2014cited by this paper
• Clusterin expression level correlates with increased oxidative stress in asthmatics.

  2014cited by this paper
• Clusterin: a key player in cancer chemoresistance and its inhibition

  2014cited by this paper
• siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.

  2014cited by this paper
• Serum Clusterin as a Tumor Marker and Prognostic Factor for Patients with Esophageal Cancer

  2014cited by this paper
• Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells

  2014cited by this paper
• Knockdown of Clusterin Expression Increases the In Vitro Sensitivity of Human Prostate Cancer Cells to Paclitaxel

  2014cited by this paper
• Comparative Studies of the Proteome, Glycoproteome, and N-Glycome of Clear Cell Renal Cell Carcinoma Plasma before and after Curative Nephrectomy

  2014cited by this paper
• RNA interference and its role in cancer therapy.

  2014cited by this paper
• Se-Methylselenocysteine Inhibits Apoptosis Induced by Clusterin Knockdown in Neuroblastoma N2a and SH-SY5Y Cell Lines

  2014cited by this paper
• Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma

  2014cited by this paper
• Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer.

  2013cited by this paper
• Cytoplasmic Clusterin Expression Correlates With Pancreatic Neuroendocrine Tumor Size and Pathological Stage

  2013cited by this paper
• Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

  2013cited by this paper
• Knockdown of clusterin inhibits the growth and migration of renal carcinoma cells and leads to differential gene expression.

  2013cited by this paper
• Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma

  2013cited by this paper
• Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer.

  2013cited by this paper
• Clusterin Protects Hepatocellular Carcinoma Cells from Endoplasmic Reticulum Stress Induced Apoptosis through GRP78

  2013cited by this paper
• Exon-Skipping Strategy by Ratio Modulation between Cytoprotective versus Pro-Apoptotic Clusterin Forms Increased Sensitivity of LNCaP to Cell Death

  2013cited by this paper
• Embryonic Origin and Remodeling of the Urinary and Digestive Outlets

  2013cited by this paper
• A review of the current status of siRNA nanomedicines in the treatment of cancer.

  2013cited by this paper
• Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway

  2013cited by this paper
• RNA interference-mediated secretory clusterin gene silencing inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cells.

  2013cited by this paper
• Epigenetic and immunohistochemical characterization of the Clusterin gene in ovarian tumors

  2013cited by this paper
• Prognostic role of clusterin in resected adenocarcinomas of the lung.

  2013cited by this paper
• Human nuclear clusterin mediates apoptosis by interacting with Bcl‐XL through C‐terminal coiled coil domain

  2012cited by this paper
• Stable Knockdown of Clusterin by Vector-Based RNA Interference in a Human Breast Cancer Cell Line Inhibits Tumour Cell Invasion and Metastasis

  2012cited by this paper
• Multidimensional liquid chromatography platform for profiling alterations of clusterin N-glycosylation in the plasma of patients with renal cell carcinoma.

  2012cited by this paper
• Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.

  2012cited by this paper
• Secreted Clusterin in Colon Tumor Cell Models and Its Potentialas Diagnostic Marker for Colorectal Cancer

  2012cited by this paper
• Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

  2012cited by this paper
• Clusterin and Chemotherapy Sensitivity Under Normoxic and Graded Hypoxic Conditions in Colorectal Cancer

  2012cited by this paper
• Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model

  2012cited by this paper
• Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer.

  2012cited by this paper
• Lentivirus-mediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro.

  2012cited by this paper
• Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.

  2012cited by this paper
• Silencing disease genes in the laboratory and the clinic

  2012cited by this paper
• Secreted CLU is associated with the initiation of triple-negative breast cancer

  2012cited by this paper
• Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma.

  2012cited by this paper
• Clinical significance of clusterin expression in pancreatic adenocarcinoma

  2012cited by this paper
• Antisense Oligonucleotide Against Clusterin Regulates Human Hepatocellular Carcinoma Invasion Through Transcriptional Regulation of Matrix Metalloproteinase-2 and E-Cadherin

  2012cited by this paper
• Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation

  2012cited by this paper
• Regulation of chemosensitivity and migration by clusterin in non-small cell lung cancer cells

  2011cited by this paper
• Clusterin induces matrix metalloproteinase‐9 expression via ERK1/2 and PI3K/Akt/NF‐κB pathways in monocytes/macrophages

  2011cited by this paper
• Current progress of siRNA/shRNA therapeutics in clinical trials

  2011cited by this paper
• Clusterin confers gmcitabine resistance in pancreatic cancer

  2011cited by this paper
• Proapoptotic role of nuclear clusterin in brain

  2011cited by this paper
• Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms.

  2011cited by this paper
• CRM1 Protein-mediated Regulation of Nuclear Clusterin (nCLU), an Ionizing Radiation-stimulated, Bax-dependent Pro-death Factor*

  2011cited by this paper
• Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c

  2011cited by this paper
• Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel

  2011cited by this paper
• Essential role of clusterin in pancreas regeneration

  2011cited by this paper
• Increase in clusterin forms part of the stress response in Hodgkin's lymphoma.

  2011cited by this paper
• Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel

  2011cited by this paper
• Molecular cloning, promoter analysis, SNP detection of Clusterin gene and their associations with mastitis in Chinese Holstein cows

  2011cited by this paper
• Effects of Female Sex Hormones on Clusterin Expression and Paclitaxel Resistance in Endometrial Cancer Cell Lines

  2011cited by this paper
• Clusterin Immunoreactivity as a Predictive Factor for Progression of Non-Muscle-Invasive Bladder Carcinoma

  2010cited by this paper
• Clusterin Expression Inversely Correlates with Chemosensitivity and Predicts Poor Survival in Patients with Locally Advanced Cervical Cancer Treated with Cisplatin-Based Neoadjuvant Chemotherapy and Radical Hysterectomy

  2010cited by this paper
• Clusterin Immunoexpression and its Clinical Significance in Patients with Non-Small Cell Lung Cancer

  2010cited by this paper
• Effects of clusterin over-expression on metastatic progression and therapy in breast cancer

  2010cited by this paper
• Clusterin expression is associated with decreased disease‐free survival of patients with colorectal carcinomas

  2010cited by this paper
• Clusterin as a Diagnostic and Prognostic Marker for Transitional Cell Carcinoma of the Bladder

  2010cited by this paper
• Treatment of prostate and breast tumors employing mono- and bi-specific antisense oligonucleotides targeting apoptosis inhibitory proteins clusterin and bcl-2

  2010cited by this paper
• Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancer.

  2010cited by this paper
• The clusterin paradigm in prostate and breast carcinogenesis.

  2010cited by this paper
• Response of bladder carcinoma cells to TRAIL and antisense oligonucleotide, Bcl-2 or clusterin treatments.

  2009cited by this paper
• Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer

  2009cited by this paper
• Regulation of Clusterin Expression in Human Cancer via DNA Methylation

  2009cited by this paper
• Clusterin overexpression and relapse-free survival in breast cancer.

  2009cited by this paper
• Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer

  2009cited by this paper
• Clusterin (CLU) and prostate cancer.

  2009cited by this paper
• Chemosensitization of gemcitabine‐resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti‐apoptotic gene, clusterin

  2009cited by this paper
• Clusterin (CLU) and lung cancer.

  2009cited by this paper

• Triple Silencing of HSP27, cFLIP, and CLU Genes Promotes the Sensitivity of Doxazosin-Induced Apoptosis in PC-3 Prostate Cancer Cells

  2024cites this paper
• Clusterin mediates hydroquinone-induced cytotoxic responses in HL-60 differentiated cells

  2024cites this paper
• Identification and clinical validation of diverse cell-death patterns-associated prognostic features among low-grade gliomas

  2024cites this paper
• Clusterin: a marker and mediator of chemoresistance in colorectal cancer

  2024cites this paper
• Increased GPC4 and clusterin associated with insulin resistance in patients with PCOS

  2024cites this paper
• Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor

  2023cites this paper
• Clusterin protects mature dendritic cells from reactive oxygen species mediated cell death

  2023cites this paper
• The Influence of Clusterin Glycosylation Variability on Selected Pathophysiological Processes in the Human Body

  2022cites this paper
• Dysregulation of HNF1B/Clusterin Axis Enhances Disease Progression in a Highly Aggressive Subset of Pancreatic Cancer Patients.

  2022cites this paper
• BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling

  2022cites this paper
• Hsa_circ_0063804 enhances ovarian cancer cells proliferation and resistance to cisplatin by targeting miR-1276/CLU axis

  2022cites this paper
• N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.

  2021cites this paper
• Proteomic Characterization of Two Extracellular Vesicle Subtypes Isolated from Human Glioblastoma Stem Cell Secretome by Sequential Centrifugal Ultrafiltration

  2021cites this paper
• Clusterin inhibits Cr(VI)-induced apoptosis via enhancing mitochondrial biogenesis through AKT-associated STAT3 activation in L02 hepatocytes.

  2021cites this paper
• The multiple roles and therapeutic potential of clusterin in non-small-cell lung cancer: a narrative review

  2021cites this paper
• Convolutional neural network in proteomics and metabolomics for determination of comorbidity between cancer and schizophrenia

  2021cites this paper
• Quantitative Serum Proteomics Reveals The Predictive and Prognostic Potential of Clusterin and Gelsolin in Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy

  2021cites this paper
• Cloning and Tissue Expression of Clusterin in Bufo gargarizans

  2020influential citation
• Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells

  2020cites this paper
• Clusterin suppresses spermatogenic cell apoptosis to alleviate diabetes‐induced testicular damage by inhibiting autophagy via the PI3K/AKT/mTOR axis

  2020cites this paper
• Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in Akt/mTOR/ULK1 dependent pathway.

  2020cites this paper
• Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p

  2020cites this paper
• Secretory Clusterin AS A Novel Molecular-targeted for Inhibiting Hepatocellular Carcinoma Growth.

  2020cites this paper
• Aberrant fucosylation enables breast cancer clusterin to interact with dendritic cell-specific ICAM-grabbing non-integrin (DC-SIGN)

  2019cites this paper
• Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1

  2019cites this paper
• Apolipoproteins as context-dependent regulators of lung inflammation

  2019cites this paper
• Glyceryl trinitrate‑induced cytotoxicity of docetaxel‑resistant prostatic cancer cells is associated with differential regulation of clusterin.

  2019cites this paper
• Immunotherapy: A Challenge of Breast Cancer Treatment

  2019cites this paper
• Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities

  2019cites this paper
• Radiosensitizing effects of Cyclocarya paliurus polysaccharide on hypoxic A549 and H520 human non-small cell lung carcinoma cells

  2019cites this paper
• Clusterin, a Novel DEC1 Target, Modulates DNA Damage–Mediated Cell Death

  2018cites this paper